The Smoking MUMS (Maternal Use of Medications and Safety) study: Protocol for a population-based cohort study using linked administrative data

BMJ Open

Volumn 3, Issue 9, 2013, Pages

  Havard, Alys ^a   Jorm, Louisa R ^a,b   Preen, David ^c   Daube, Michael ^d   Kemp, Anna ^c   Einarsdóttir, Kristjana ^e   Randall, Deborah ^a   Tran, Duong Thuy ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b SAX INSTITUTE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

ARTICLE; AUSTRALIA; CAUSE OF DEATH; CHILD HEALTH; CHILDBIRTH; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MATERNAL WELFARE; MOTHER; POPULATION RESEARCH; PREGNANCY; PRESCRIPTION; SMOKING CESSATION; SOCIAL SECURITY;

EID: 84885400588     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003692     Document Type: Article

References (55)

1. Hammoud A, Bujold E, Sorokin Y, et al. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 2005;192:1856-63. (Pubitemid 40827056)
2. Wisborg K, Kesmodel U, Henrisksen T, et al. Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2001;154:322-7. (Pubitemid 32756628)
3. Wong P, Bauman A. How well does epidemiological evidence hold for the relationship between smoking and adverse obstetric outcomes in New South Wales. Aust N Z J Obstet Gynaecol 1997;37:168.
4. Mitchell E, Milerad J. Smoking and the sudden infant death syndrome. Rev Environ Health 2006;21:81-103. (Pubitemid 44077519)
5. Jaakkola J, Gissler M. Maternal smoking in pregnancy, fetal development and childhood asthma. Am J Public Health 2004;94:136-40. (Pubitemid 38196924)
6. Wisborg K, Henrisksen T, Obel C, et al. Smoking during pregnancy and hospitalization of the child. Pediatrics 1999;104:e46.
7. Mohsin M, Bauman A, Forero R. Socioeconomic correlates and trends in smoking in pregnancy in New South Wales, Australia. J Epidemiol Community Health 2011;65:727-32.
8. Li Z, Zeki R, Hilder L, et al. Australia's mothers and babies 2010. Canberra: AIHW National Perinatal Epidemiology and Statistics Unit, 2012.
9. Li C, Windsor R, Perkins L, et al. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269:1519-24. (Pubitemid 23086412)
10. Lumley J, Chamberlain C, Dowswell T, et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009;(3):CD001055.
11. Schneider S, Huy C, Schutz J, et al. Smoking cessation during pregnancy: a systematic literature review. Drug Alcohol Rev 2010;29:81-90.
12. Cnattingius S, Lindmark G, Meirik O. Who continues to smoke while pregnant? J Epidemiol Community Health 1992;46:218-21.
13. Jane M, Nebot M, Badi M, et al. Determinant factors of smoking cessation during pregnancy. Med Clin (Barc). 2000;114:132-5.
14. Mohsin M, Bauman A. Socio-demographic factors associated with smoking and smoking cessation among 426,344 pregnant women in New South Wales, Australia. BMC Public Health 2005;5:138.
15. Carrozi L, Pistelli F, Viegi G. Review: pharmacotherapy for smoking cessation. Ther Adv Respir Dis 2008;2:301.
16. Sutherland G, Stapleton J, Russell M, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-9.
17. Perez D, Cotter T, Makino K, et al. Pharmacotherapy evaluation: drugs that assist smoking cessation. Sydney: Cancer Institute NSW, 2008.
18. MIMS Australia Pty Ltd. MIMS Online. CMPMedica Australia Pty Ltd. 2011. [cited 2011 24 February]. https://www.mimsonline.com.au/Search/Search.aspx
19. Australian Government Department of Health and Ageing. The extension of the listing of nicotine patches on the Pharmaceutical Benefits Scheme from 1 February 2011. 2011. http://www.pbs.gov.au/info/publication/factsheets/shared/ Extension-of-the-listing-of-nicotine-patches
20. Australian Government Department of Health and Ageing. Browse the PBS: Browse by body system. [cited 2013 January 22]. http://www.pbs.gov.au/browse/ body-system?depth=4&codes=n07ba
21. Strandberg-Larsen K, Tinggaard M, Nybo Andersen A-M, et al. Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study. BJOG 2008;115:1405-10.
22. Irvine L, Flynn R, Libby G, et al. Drugs dispensed in primary care during pregnancy; a record-linkage analysis in Tayside, Scotland. Drug Saf 2010;33:593-605.
23. Rigotti N, Park E, Chang Y, et al. Smoking cessation medication use among pregnant and postpartum smokers. Obstet Gynecol 2008;111:348-55. (Pubitemid 351653425)
24. Oncken C, Pbert L, Ockene J, et al. Nicotine replacement prescription practices of obstetric and pediatric clinicians. Obstet Gynecol 2000;96:261-5. (Pubitemid 30447350)
25. Price J, Jordan T, Dake J. Obstetricians and gynecologists' perceptions and use of nicotine replacement therapy. J Community Health 2006;31:160-75. (Pubitemid 43781347)
26. Herbert R, Coleman T, Britton J. U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy. Nicotine Tob Res 2005;7:541-6. (Pubitemid 41600912)
27. Cahill K, Stevens S, Perera R, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev [serial on the Internet]. 2013;(5): CD009329. http://summaries.cochrane. org/CD009329/medications-to-help-people-to-stop-smoking-an-overview-of-reviews
28. Coleman T, Chamberlain C, Cooper S, et al. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011;106:52-61.
29. Kemp A, Roughead E, Preen D, et al. How much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries. Aust Health Rev 2011;35:341-9.
30. Scottish Executive. Review of prescription charges in Western Europe, North American and Australasia. Edinburgh. 2006. [cited 8 Mar 2011]. http://www.scotland.gov.uk/Resource/Doc/92240/0022048.pdf
31. Hynd A, Roughead E, Preen D, et al. The impact of co-payment changes on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf 2008;17:1091-9.
32. Alwan S, Reefhuis J, Botto L, et al. Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol 2010;203:e1-6.
33. Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005;192:932-6. (Pubitemid 40311292)
34. Cole J, Modell J, Haight B, et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007;16:474-84. (Pubitemid 46824268)
35. GlaxoSmithKline. GlaxoSmithKline Bupropion Pregnancy Registry. Final report: 1 September 1997 through 31 March 2008. Registry Report. Wilmington, NC, 2008.
36. Chan B, Einarson A, Koren G. Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis 2005;24:19-23. (Pubitemid 40604648)
37. Coleman T. Recommendations for the use of pharmacological smoking cessation strategies in pregnant women. CNS Drugs 2007;21:983-93. (Pubitemid 350136782)
38. Pollak K, Oncken C, Lipkus I, et al. Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. Nicotine Tob Res 2006;8:547-54. (Pubitemid 44263588)
39. Morales-Suarez-Varela M, Bille C, Christensen K, et al. Smoking habits, nicotine use and congenital malformations. Obstet Gynecol 2006;107:51-7.
40. Dietz P, Adams M, Rochat R, et al. Prenatal smoking in two consecutive pregnancies: Georgia, 1989-1992. Matern Child Health J 1997;1:43-51.
41. National Centre for Classification in Health. The International Statistical Classiication of Diseases and Related Health Problems, 10th Revision, Australian modification (ICD-10-AM). Vol. 3. ICD-10-AM Tabular list of procedures. Sydney: Faculty of Health Sciences, University of Sydney, 2006.
42. Kelman C, Bass A, Holman C. Research use of linked health data - a best practice protocol. Aust N Z J Public Health 2002; 26:251-5. (Pubitemid 35446374)
43. Centre for Health Record Linkage. Quality Assurance in Record Linkage: 20 December 2009. CHeReL; [cited 16 Mar 2011]. http://www.cherel.org.au/ CHeReLQualityAssuranceJuly2008.pdf
44. Holman C, Bass A, Rouse I, et al. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999;23:453-9. (Pubitemid 29479210)
45. Australian Bureau of Statistics. SEIFA: socio-economic indexes for areas. Canberra: Australian Bureau of Statistics, 2008. [cited 15 Mar 2011]. http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Seifa-entry-page
46. Australian Bureau of Statistics. Australian standard geographical classification (ASGC). Canberra: Australian Bureau of Statistics, 2005. [cited 14 Mar 2011]. http://www.abs.gov.au/AUSSTATS/abs@nsf/0/ 0D204FD3DCD90564CA256F19001303A2?opendocument
47. Colvin L, Slack-Smith L, Stanly F, et al. Pharmacovigilance in pregnancy using population-based linked datasets. Pharmacoepidemiol Drug Saf 2009;18:211-25.
48. Zwar N, Richmond R, Borland R, et al. Smoking cessation pharmacotherapy: an update for health professionals. Melbourne: The Royal Australian College of General Practitioners, 2007.
49. Laws P, Li Z, Sullivan E. Australia's mothers and babies 2008. Canberra: AIHW, 2010. Contract No.: Cat. no. PER 50.
50. Laws P, Sullivan E. Australia's mothers and babies 2003. Sydney: AIHW National Perinatal Statistics Unit, 2005. Contract No.: Cat. No. PER 29.
51. Medicare Australia. Pharmaceutical Benefits Schedule Item Reports. 2011. [cited 14 Mar 2011]. https://www.medicareaustralia.gov.au/statistics/pbs-item. shtml
52. Beaty T, Yang P, Munoz A, et al. Effect of maternal and infant covariates on sibship correlation in birth weight. Genet Epidemiol 1988;5:241-53.
53. Australian Government Department of Health and Ageing. Indigenous Health. 2010. [cited 1 Mar 2011]. http://www.medicareaustralia.gov.au/provider/ patients/indigenous.jsp#N10096
54. Taylor L, Pym M, Bajuk B, et al. NSW mothers and babies. NSW Public Health Bull Suppl 2000;1:97-9.
55. Taylor L, Travis S, Pym M, et al. How useful are hospital morbidity data for monitoring conditions occurring in the perinatal period. Aust N Z J Obstet Gynecol 2005;45:36-41. (Pubitemid 40424713)